Combined Multiagent Chemotherapy and Radiotherapy Is Associated with Improved Survival Compared to Chemotherapy Alone in Patients with Non-Operatively Managed Stage II-III Pancreatic Adenocarcinoma. (2022) - Sugumar, K.; Hue, J.; Hardacre, J.; Ammori, J.; Rothermel, L.; Dorth, J.; Saltzman, J.; Mohamed, A.; Selfridge, J.; Bajor, D.; Winter, J.; Ocuin, L.